Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

CH BIOTECH SER

0.780
0.000
Volume:520.00K
Turnover:417.00K
Market Cap:761.07M
PE:-3.81
High:0.860
Open:0.820
Low:0.780
Close:0.780
Loading ...
OverviewCompanyNewsFilings

Concept

Suspected Financial Misconduct+5.44%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

BRIEF-China Biotech Services Signs Memorandum Of Understanding With Stella Pharma Corporation

Reuters
·
08 May

China Biotech Services - Memorandum of Understanding Signed With Stella Pharma Corporation for Sales and Production of Steboronine

THOMSON REUTERS
·
08 May

China Biotech Services - Bank of Shanghai, Pudong Branch to Provide Credit Line in Principal Amount of up to RMB4 Mln to Shanghai Longyao

THOMSON REUTERS
·
24 Apr

China Biotech Services Holdings Full Year 2024 Earnings: HK$0.20 loss per share (vs HK$0.099 loss in FY 2023)

Simply Wall St.
·
31 Mar

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Mar 28, 2025 Post Market
Financial Report Announcement
Aug 26, 2024 Post Market
Financial Report Announcement
Mar 28, 2024
Financial Report Announcement
Nov 13, 2023
Financial Report Announcement
Aug 11, 2023

Dividend History

Ex-DateDividend
2015-08-170
2023-05-190.01

Valuation Analysis

-3.84
Current
2.57
Sector Average
18.12%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-3.84
Maximum
70.56
+1 STD
27.65
Minimum
-104.00
-1 STD
-22.51
Average
2.57

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.